India to Belgium: Bortezomib Export Trade Route
India has recorded 20 verified shipments of Bortezomib exported to Belgium, representing a combined trade value of $871.4K USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $43.6K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED, which accounts for 62% of total export value with 11 shipments worth $539.8K USD. On the buying side, YUSEN LOGISTICS BENELUX BELGIUM is the largest importer in Belgium with $539.8K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Belgium Bortezomib corridor is one of India's established pharmaceutical export routes, with 20 shipments documented worth a combined $871.4K USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 62% of all export value, reflecting the consolidated nature of India's bortezomib manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $43.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (68%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during July–September, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 30.4%, placing it at rank #16 among India's top bortezomib export destinations globally.
On the import side, key buyers of Indian bortezomib in Belgium include YUSEN LOGISTICS BENELUX BELGIUM, YUSEN LOGISTICS BENELUX BELGIUM . YUSEN LOGISTICS BENELUX BELGIUM is the single largest importer with 11 shipments valued at $539.8K USD.
Route Characteristics
- Average transit
